comprehensive -WSS

comprehensive

author：entertainment 2025-09-06 05:03:13 - browse：91

Outgoing Bristol CEO Giovanni Caforio Emilie Pickering for STAT

It’s changing of the guard time at pharmaceutical giant Bristol Myers Squibb. On Wednesday, CEO Giovanni Caforio will step down. He’ll be replaced by Christopher Boerner, who is currently chief operating officer.

When Caforio took over in May 2015, Bristol was known as a big pharmaceutical firm with the high-flying stock of a biotechnology company, largely due to its role as the company that brought cancer immunotherapy to market. But Bristol stumbled in 2016 when its immunotherapy Opdivo failed to help patients with non-small cell cancer more than chemotherapy. Opdivo remained a big seller, but its failure allowed Merck’s rival Keytruda to move into position to become the best-selling medicine in the world. In 2019, Caforio tried to flip the script, buying the biotech Celgene for $74 billion.

STAT recently sat down with Caforio, 59, to look back on what went wrong and right with his tenure. He also reflected on what it meant to be a physician — and the son of a physician. “We were speaking about patient stories over lunch and dinner, when I was a kid, and I think that drove my passion for medicine,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Roivant's CEO is a star, but biotech's black hole persists

leisure time

WSS

CVS is on a mission to consolidate health care. Will it work?

Medicare bonuses could stop drug shortages under Senate plan

FDA clears Verve to begin U.S. study of gene

Readout LOUD podcast: Live from the 2023 STAT Summit

CVS is on a mission to consolidate health care. Will it work?

Medicare bonuses could stop drug shortages under Senate plan

Wikipedia

comprehensive

hotspot

Medicare proposal to cover medical devices draws a mixed reaction

Study on Amgen’s bispecific immunotherapy produces positive data

In age of alternative facts, a scholarly course on calling out crap

Roivant's CEO is a star, but biotech's black hole persists

Drug repurposing or repositioning? The language matters

What causes osteoarthritis? Researchers study link to brain protein

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

A pediatrician calls for Congress to pass the child tax credit deal

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

focus

HPV vaccine, cervical cancer study delivers historic results

Update the Apgar Score to remove skin color

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

J&J lung cancer data amount to new salvo against AstraZeneca

What causes osteoarthritis? Researchers study link to brain protein

Readout LOUD podcast: Live from the 2023 STAT Summit

leisure time

focus

focus

hotspot